Biotech continues to remain one of the most interesting fields of investment in the overall health care sector. However, not all biotech companies can succeed. Many focused on research and development end up winding down because of failure in their efforts, making the biotech sector investment a tricky one. It is difficult for individual investors to understand the intricacies of the biotech companies working and the complexities of the medical world. Biotech exchange-traded funds (ETF) allow an easy and convenient way to not only diversify and spread the invested capital across a variety of biotech stocks, they also make such investments economical as one only needs to pay a standard expense. Following is the list of all 42 exchange-traded funds that FKnol has in its database for ETFs which belong to the Biotech category:
The ARK Genomic Revolution Multi-Sector ETF is an actively managed fund that targets companies involved in the genomics industry. ...Detailed Profile Dividend Frequency: Annually Dividend History
Category: Health & Biotech Equities
The Virtus LifeSci Biotech Clinical Trials ETF tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. ...Detailed Profile Dividend Frequency: Annually Dividend History
Category: Health & Biotech Equities
The Virtus LifeSci Biotech Products ETF tracks an index of biotechnology companies considered to be in the "product stage" by the index provider. ...Detailed Profile Dividend Frequency: Annually Dividend History
Category: Health & Biotech Equities
The ProShares Ultra NASDAQ Biotech provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. ...Detailed Profile Dividend Frequency: Quarterly Dividend History
Category: Leveraged Equities
$50.24
-11.94%
0.95%
191
6.
ETF Biotech ZVZZT Corp Ltd. (ZVZZT)
The ETF Biotech belonging to the Equity category, Multi-Cap sub-sector and trading in the US market has the following ETF profile. ...See
The Principal Healthcare Innovators Index ETF tracks an index of non-large-cap US health care stocks and is market cap weighted. ...Detailed Profile Dividend Frequency: Annually Dividend History
Category: Health & Biotech Equities
This fund tracks the Loncar Cancer Immunotherapy Index, an equal-weighted index of companies currently producing or in clinical trials for cancer immunotherapy drugs. ...Detailed Profile Dividend Frequency: Annually Dividend History
Category: Health & Biotech Equities
Imagine purchasing five or 10 different biotech companies stocks after lot of study, against purchasing units of a well-diversified biotech ETF at a low cost. Such biotech ETFs work by either replicating the holdings of a particular biotech focused index, or by actively researching and picking only certain biotech stocks that fit the stated investment objective of the ETF. Such ETFs offer great convenience to the investors by offering a diversified mix of biotech stocks which can be held as a single unit, though one should be aware of the sector-specific risks. If the overall biotech sector is falling owing to various reasons, the returns from the biotech ETF may also follow suit. One can also find leveraged biotech ETFs which attempt to magnify the returns generated by the underlying biotech index by a particular factor. For instance, there is the Direxion Daily S&P Biotech Bear 3x Shares (LABD) ETF which magnifies the returns of the underlying biotech index by a factor of (-3), while the Direxion Daily S&P Biotech Bull 3x Shares (LABU) ETF magnifies the returns by a factor of (+3).
Where do Biotech ETFs Invest?
A long list of companies and different financial instruments exist where the Biotech exchange-traded funds may invest the money collected from the ETF investors. Below is a small sample of companies whose stocks may qualify for investment by Biotech ETFs, though there can be many more businesses and financial instruments where these ETFs can park the capital for returns:
▶ Novo Nordisk A/S (NVO): Novo Nordisk A S, a healthcare company, engages in the development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Obesity, and Bi....Detailed Company Profile....Dividend History
▶ Vertex Pharmaceuticals Inc (VRTX): Vertex Pharmaceuticals Incorporated, incorporated on January 4, 1989, is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for ....Detailed Company Profile....Dividend History
▶ Regeneron Pharmaceuticals, Inc. (REGN): Regeneron Pharmaceuticals, Inc., incorporated on January 11, 1988, is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes ....Detailed Company Profile....Dividend History
▶ Incyte Corporation (INCY): Incyte Corporation, incorporated on April 8, 1991, is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics. The Companys portfolio includes compounds in various ....Detailed Company Profile....Dividend History
▶ Alexion Pharmaceuticals (ALXN): Alexion Pharmaceuticals, Inc., incorporated on January 28, 1992, is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Companys products include Soliris (eculizumab), ....Detailed Company Profile....Dividend History
▶ Sarepta Therapeutics, Inc. (SRPT): Sarepta Therapeutics, Inc., incorporated on June 5, 2013, is a biopharmaceutical company. The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of ....Detailed Company Profile....Dividend History
▶ Seattle Genetics, Inc. (SGEN): Seattle Genetics, Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-d....Detailed Company Profile....Dividend History